Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Lazertinib, a Third Generation EGFR-TKI, in Patients with EGFR-TKI-Resistant NSCLC: Updated Results of a Phase I/II Study
- Authors
- Cho, B. C.; Han, J.; Kim, S.; Lee, K.; Kim, D.; Lee, Y.; Lee, G.; Lee, J.; Cho, E. K.; Kim, J.; Lee, S. S.; Min, Y. J.; Kim, J.; Shin, S. W.; Kim, H. R.; Hong, M. H.; Ahn, J. S.; Kang, S.; Kim, S.; Jang, S. B.; Choi, S.; Ahn, M.
- Issue Date
- 10월-2018
- Publisher
- ELSEVIER SCIENCE INC
- Keywords
- Lazertinib; T790M; 3rd generation EGFR TKI
- Citation
- JOURNAL OF THORACIC ONCOLOGY, v.13, no.10, pp.S453 - S453
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF THORACIC ONCOLOGY
- Volume
- 13
- Number
- 10
- Start Page
- S453
- End Page
- S453
- ISSN
- 1556-0864
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.